The GABAA receptor: a novel target for treatment of fragile X?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Trends in Neurosciences

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/J.TINS.2007.06.003PMID 17590448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Encyclopedia of molecular cell biology and molecular medicine

  2014cited by this paper
• Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein.

  2007cited by this paper
• Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

  2007cited by this paper
• A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability

  2007cited by this paper
• Neurochemical regulation of sleep.

  2007cited by this paper
• Neurosteroids, GABAA receptors, and ethanol dependence

  2006cited by this paper
• Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model.

  2006cited by this paper
• Corticosterone response to acute stress in a mouse model of Fragile X syndrome.

  2006cited by this paper
• Gaboxadol--a new awakening in sleep.

  2006cited by this paper
• Decreased expression of the GABAA receptor in fragile X syndrome.

  2006cited by this paper
• Social behavior and cortisol reactivity in children with fragile X syndrome.

  2006cited by this paper
• Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor–mediated mechanisms

  2006cited by this paper
• Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome.

  2006cited by this paper
• Fragile X-Linked Mental Retardation

  2006cited by this paper
• Further potential of the GABA receptor in the treatment of insomnia

  2006cited by this paper
• The fragile X syndrome: exploring its molecular basis and seeking a treatment

  2006cited by this paper
• Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.

  2006cited by this paper
• GABA modulates day-night variation in melatonin levels in the cerebral ganglia of the damselfly Ischnura graellsii and the grasshopper Oedipoda caerulescens.

  2005cited by this paper
• Fathoming fragile X in fruit flies.

  2005cited by this paper
• Inherited disorders of neurotransmitters in children and adults.

  2005cited by this paper
• Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.

  2005cited by this paper
• The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics

  2005cited by this paper
• Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.

  2004cited by this paper
• GABA pharmacology--what prospects for the future?

  2004cited by this paper
• GABAA receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil

  2004cited by this paper
• RNA and microRNAs in fragile X mental retardation

  2004cited by this paper
• Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice.

  2004cited by this paper
• Neuropsychiatric Symptoms of Fragile X Syndrome

  2004cited by this paper
• The neuroanatomy and neuroendocrinology of fragile X syndrome.

  2004cited by this paper
• The mGluR theory of fragile X mental retardation.

  2004cited by this paper
• Attention and language in fragile X.

  2004cited by this paper
• Defective Neuronal Development in the Mushroom Bodies of Drosophila Fragile X Mental Retardation 1 Mutants

  2004cited by this paper
• Understanding fragile X syndrome: insights from animal models

  2003cited by this paper
• The GABA(A) receptor mediates the hypnotic activity of melatonin in rats.

  2003cited by this paper
• RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

  2003cited by this paper
• Involvement of cholinergic and gabaergic systems in the fragile X knockout mice.

  2003cited by this paper
• Of mice and the fragile X syndrome.

  2003cited by this paper
• Fragile X syndrome: diagnosis, treatment and research

  2003cited by this paper
• A new benzodiazepine pharmacology.

  2002cited by this paper
• Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.

  2002cited by this paper
• The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression.

  2002cited by this paper
• Drug interactions at GABA(A) receptors.

  2002cited by this paper
• A decade of molecular studies of fragile X syndrome.

  2002cited by this paper
• Behavior and Physiology of Mice Lacking the GABAA‐Receptor δ Subunit

  2002cited by this paper
• Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain.

  2002cited by this paper
• The human γ-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression

  2002cited by this paper
• Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest.

  2002cited by this paper
• Altered synaptic plasticity in a mouse model of fragile X mental retardation

  2002cited by this paper
• Behavior and physiology of mice lacking the GABAA-receptor delta subunit.

  2002cited by this paper
• Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice.

  2002cited by this paper
• The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif

  2001cited by this paper
• First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene

  2001cited by this paper
• Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function.

  2001cited by this paper
• Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function

  2001cited by this paper
• GABAergic Mechanisms in Epilepsy

  2001cited by this paper
• Fragile X mice develop sensory hyperreactivity to auditory stimuli.

  2001cited by this paper
• Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study.

  2000cited by this paper
• Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle.

  2000cited by this paper
• Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

  2000cited by this paper
• Sleep in subjects with autistic disorder: a neurophysiological and psychological study.

  2000cited by this paper
• Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome

  2000cited by this paper
• Characterization of dFMR1, a Drosophila melanogaster Homolog of the Fragile X Mental Retardation Protein

  2000cited by this paper
• Epilepsy and EEG Findings in Males with Fragile X Syndrome

  1999cited by this paper
• Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

  1999cited by this paper
• Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis.

  1999cited by this paper
• Mice Lacking the β3 Subunit of the GABAA Receptor Have the Epilepsy Phenotype and Many of the Behavioral Characteristics of Angelman Syndrome

  1998cited by this paper
• International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

  1998cited by this paper
• Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior.

  1997cited by this paper
• Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

  1997cited by this paper
• Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior

  1997cited by this paper
• Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

  1997cited by this paper
• The fragile X mental retardation protein is associated with ribosomes

  1996cited by this paper
• GABAA‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits

  1995cited by this paper
• FMR1 Knockout mice: A model to study fragile X mental retardation

  1994cited by this paper
• Absence of expression of the FMR-1 gene in fragile X syndrome.

  1991cited by this paper
• Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

  1991cited by this paper
• Prevalence of a novel epileptogenic EEG pattern in the Martin-Bell syndrome.

  1988cited by this paper
• Pharmacology of Benzodiazepine Antagonists

  1985cited by this paper
• Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex.

  1984cited by this paper

• From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research

  2025cites this paper
• A longitudinal investigation of pragmatic language across contexts in autism and related neurodevelopmental conditions

  2023cites this paper
• Autism Spectrum Disorder with Epilepsy: A Research Protocol for a Clinical and Genetic Study

  2023cites this paper
• Rescue of sharp wave-ripples and prevention of network hyperexcitability in the ventral but not the dorsal hippocampus of a rat model of fragile X syndrome

  2023cites this paper
• Neurodevelopment and early pharmacological interventions in Fragile X Syndrome

  2023cites this paper
• Cellular and molecular mechanisms underlying autism spectrum disorders and associated comorbidities: A pathophysiological review.

  2022cites this paper
• New Animal Models for Understanding FMRP Functions and FXS Pathology

  2022cites this paper
• Keeping Excitation–Inhibition Ratio in Balance

  2022cites this paper
• Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1.

  2022cites this paper
• From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systems

  2022cites this paper
• Agmatine relieves behavioral impairments in Fragile X mice model.

  2022cites this paper
• GABAergic circuits of the basolateral amygdala and generation of anxiety after traumatic brain injury

  2022cites this paper
• Synthesis and evaluation of avermectin-imidazo[1,2-a]pyridine hybrids as potent GABAA receptor modulators.

  2022cites this paper
• Reversing GABA polarity corrects synaptic physiology and behavioural deficits in young adolescent Syngap1+/- mice

  2021cites this paper
• Pharmacological intervention in young adolescents rescues synaptic physiology and behavioural deficits in Syngap1+/− mice

  2021cites this paper
• RNA-binding proteins balance brain function in health and disease.

  2020cites this paper
• Modelling learning and memory in Drosophila to understand Intellectual Disabilities.

  2020influential citation
• Single-Cell and Neuronal Network Alterations in an In Vitro Model of Fragile X Syndrome.

  2020cites this paper
• Fragile X clinical features and neurobiology

  2020cites this paper
• Pharmacological treatments for fragile X syndrome based on synaptic dysfunction.

  2020cites this paper
• Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders

  2019cites this paper
• Patient-Derived Stem Cells, Another in vitro Model, or the Missing Link Toward Novel Therapies for Autism Spectrum Disorders?

  2019cites this paper
• GABAergic abnormalities in the fragile X syndrome.

  2019cites this paper
• Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome

  2019cites this paper
• Single-cell and neuronal network alterations in an in vitro model of Fragile X syndrome

  2018cites this paper
• Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model

  2018cites this paper
• Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders

  2018cites this paper
• Methyleugenol counteracts anorexigenic signals in association with GABAergic inhibition in the central amygdala

  2018cites this paper
• The GABAergic System Contributions to the Fragile X Syndrome Phenotype

  2017cites this paper
• Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C‐dependent mechanism

  2017cites this paper
• Fragile X syndrome

  2017cites this paper
• Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome

  2017cites this paper
• The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?

  2017cites this paper
• Title A randomized double-blind , placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome

  2017cites this paper
• Clinical, molecular, and pharmacological aspects of FMR1 related disorders.

  2017cites this paper
• 2 GABAergic Dysfunction in Autism and Epilepsy

  2017cites this paper
• A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome

  2017cites this paper
• Clinical, molecular, and pharmacological aspects of FMR1 related disorders.

  2017cites this paper
• Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines

  2017cites this paper
• Arbaclofen in fragile X syndrome: results of phase 3 trials

  2017cites this paper
• Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice

  2017cites this paper
• Epigenetic causes of intellectual disability—the fragile X syndrome paradigm

  2017cites this paper
• Identifying barriers to clinical trial participation with families affected by fragile X syndrome

  2017cites this paper
• Association of rare missense variants in the second intracellular loop of NaV1.7 sodium channels with familial autism

  2016cites this paper
• Cortical development & plasticity in the FMRP KO mouse

  2016cites this paper
• What Mechanisms Induce Methylation of FMR1 Gene Full Mutation? A Still Unanswered Question

  2016cites this paper
• Neuropathological Mechanisms of Seizures in Autism Spectrum Disorder

  2016cites this paper
• Layer-specific potentiation of network GABAergic inhibition in the CA1 area of the hippocampus

  2016cites this paper
• Review of targeted treatments in fragile X syndrome.

  2016cites this paper
• Neurodevelopmental Defects Associated with Gestational Exposure to Low Levels of DBP in Mice

  2016cites this paper
• Developmental profiles of infants with an FMR1 premutation

  2016cites this paper
• The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions

  2016cites this paper
• Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation

  2016cites this paper
• Fragile X syndrome: A review of clinical management.

  2016cites this paper
• Genes with high penetrance for syndromic and non-syndromic autism typically function within the nucleus and regulate gene expression

  2016cites this paper
• Chromatin changes caused by expansion of CGG repeats in fmr1 gene

  2015cites this paper
• Hierarchical Classes Analysis (HICLAS): A novel data reduction method to examine associations between biallelic SNPs and perceptual organization phenotypes in schizophrenia

  2015cites this paper
• Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients

  2015cites this paper
• DSM-5 Changes and the Prevalence of Parent-Reported Autism Spectrum Symptoms in Fragile X Syndrome

  2015cites this paper
• The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders.

  2015cites this paper
• 5 Altered sensitive time window in medial entorhinal cortex of Fmr 1-KO mice

  2015cites this paper
• Psychosis and catatonia in fragile X: Case report and literature review.

  2015cites this paper
• Regulation of GABAARs by phosphorylation.

  2015cites this paper
• Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.

  2015cites this paper
• Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

  2015cites this paper
• Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter.

  2015cites this paper
• R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome

  2015cites this paper
• Modeling autism-relevant behavioral phenotypes in rats and mice: Do ‘autistic’ rodents exist?

  2015cites this paper
• The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome

  2015cites this paper
• Progress Toward Therapies and Interventions for Neurodevelopmental Disorders

  2015cites this paper
• Gamma Aminobutyric Acidergic and Neuronal Structural Markers in the Nucleus Accumbens Core Underlie Trait-like Impulsive Behavior

  2014influential citation
• FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry

  2014cites this paper
• Bryostatin-1 Restores Hippocampal Synapses and Spatial Learning and Memory in Adult Fragile X Mice

  2014cites this paper
• Analysis of Fmr1 Deletion in a Subpopulation of Post‐Mitotic Neurons in Mouse Cortex and Hippocampus

  2014cites this paper
• Electrophysiological characterization of methyleugenol: a novel agonist of GABA(A) receptors.

  2014cites this paper
• Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us

  2014cites this paper
• GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model.

  2014cites this paper
• Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder

  2014cites this paper
• Fragile X syndrome neurobiology translates into rational therapy.

  2014cites this paper
• New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model.

  2014cites this paper
• Medication Management of Fragile X Syndrome

  2014cites this paper
• Tonic GABAA-Receptor-Mediated Inhibition in Fragile-X Syndrome: A Cause of Dysfunction or a Pathway for a Cure?

  2014cites this paper
• GABAA Receptor Genetics and Clinical Pharmacology

  2014cites this paper
• Die Reaktivierung der FMR1-Transkription in Fibroblasten von Patienten mit Fragilem-X-Syndrom durch Methotrexat

  2014cites this paper
• DSM-5 Changes and the Prevalence of Parent-Reported Autism Spectrum Symptoms in Fragile X Syndrome

  2014cites this paper
• Targeting the endocannabinoid system in the treatment of fragile X syndrome

  2013cites this paper
• Understanding Synaptic and Circuit Disruptions of Excitatory and Inhibitory Function In Fragile X Mental Retardation

  2013cites this paper
• Fragile X Syndrome: Steps towards Therapy

  2013cites this paper
• Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

  2013cites this paper
• Prevalence and risk of migraine headaches in adult fragile X premutation carriers

  2013cites this paper
• Fragile X syndrome: from targets to treatments.

  2013cites this paper
• Fragile X syndrome: From protein function to therapy

  2013cites this paper
• Circuit level defects in the developing neocortex of fragile X mice

  2013cites this paper
• The FMRP regulon: from targets to disease convergence

  2013cites this paper
• Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome

  2013cites this paper
• Epilepsy in four genetically determined syndromes of intellectual disability.

  2013cites this paper
• A Target Cell-Specific Role for Presynaptic Fmr1 in Regulating Glutamate Release onto Neocortical Fast-Spiking Inhibitory Neurons

  2013cites this paper
• Electrocortical changes associated with minocycline treatment in fragile X syndrome

  2013cites this paper
• The challenges of clinical trials in fragile X syndrome

  2013cites this paper
• Targeted therapies for fragile X syndrome: current state and future direction of clinical trials in humans

  2013cites this paper